Fludarabine phosphate - Drug Shortage Information

Public shortage context is available across 4 visible exact NDC pages for this generic family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Current and historical shortage references are available across related Fludarabine phosphate presentations from multiple manufacturers.

2 current shortage context pages.
2 historical shortage context pages.
4 manufacturers represented.

Related research paths

Fludarabine phosphate catalog familyBrowse all visible Fludarabine phosphate presentations in the broader catalog.Actavis Pharma, Inc.1 shortage-bearing exact NDC page.Areva Pharmaceuticals1 shortage-bearing exact NDC page.Fresenius Kabi USA, LLC1 shortage-bearing exact NDC page.

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Fludarabine phosphate 50 mg / 2mL Injection 2 mL - NDC 45963-0609-55Actavis Pharma, Inc. | 1 Vial, Glass Fludarabine Phosphate 25 mg / mL Injection 2 mL - NDC 25021-0242-02Sagent Pharmaceuticals | 1 Vial Fludarabine Phosphate 25 mg / mL Injection 2 mL - NDC 59923-0604-02Areva Pharmaceuticals | 1 Vial, Single-Dose Fludarabine Phosphate 25 mg / mL Injection 2 mL - NDC 63323-0192-02Fresenius Kabi USA, LLC | 1 Vial

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug Name	NDC 11	Manufacturer	Shortage Context
Fludarabine phosphate 50 mg / 2mL Injection 2 mL NDC 45963-0609-55 \| 1 Vial, Glass \| Actavis Pharma, Inc.	45963-0609-55	Actavis Pharma, Inc.	Current shortage context
Fludarabine Phosphate 25 mg / mL Injection 2 mLPRN Watchlist NDC 25021-0242-02 \| 1 Vial \| Sagent Pharmaceuticals	25021-0242-02	Sagent Pharmaceuticals	Current shortage context
Fludarabine Phosphate 25 mg / mL Injection 2 mLPRN Watchlist NDC 59923-0604-02 \| 1 Vial, Single-Dose \| Areva Pharmaceuticals	59923-0604-02	Areva Pharmaceuticals	Historical shortage context
Fludarabine Phosphate 25 mg / mL Injection 2 mLPRN Watchlist NDC 63323-0192-02 \| 1 Vial \| Fresenius Kabi USA, LLC	63323-0192-02	Fresenius Kabi USA, LLC	Historical shortage context

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.